Are you or a loved one at risk?
For millions of people suffering from intermediate dry age-related macular degeneration, AREDS vitamin formulations are helpful, and they are currently the only treatment available.
Zinc is considered to be a key ingredient in that supplement formula. However, for 13-19 percent of the population with particular genetic markers, the zinc in AREDS supplements may actually speed up the progression of the disease.
Now there’s an easy way to tell if zinc might be a problem for you—or if you’re at risk for macular degeneration. Your doctor can prescribe a simple and painless cheek swab genetic test that can help you and your doctor better understand your risk. The cost is about $500 and it is accepted by many health insurance companies.
The Macular Degeneration Association is leading the national effort to spread the word about supplement risks, genetic testing and other emerging research related to this disease. Genetic testing and personalized medicine are revolutionizing the way doctors treat many diseases. If you’re at risk, talk to your doctor today about genetic testing.